With a proven track record in regenerative medicine, you’re in safe hands.
Bursitis is a common but painful condition that affects major joints such as the shoulders, elbows, hips, and knees. It occurs when the bursa sacs become inflamed. The bursa are fluid-filled sacs that provide a cushion between our bones and soft tissues. When inflamed, they cause pain, swelling and reduced movement.
The condition typically occurs in people aged over 40. It can often be treated whilst resting at home by applying an ice pack wrapped in a towel to the affected area. Where symptoms persist, there are a number of conventional medical treatments available, which may include antibiotics, steroid injections, or even surgery.
Research suggests that stem cell therapy may also be an alternative option for treating some of the underlying conditions that may cause chronic bursitis. Where there is an established medial need, a clinician may prescribe stem cell therapy as a regenerative treatment in the UK, in accordance with regulation the Human Tissue Authority.
“Regenerative treatments are an option for people who may have already tried, or considered, conventional treatments. Research using stem cells with latest technology has shown promising results.”
“Stem cells are located throughout the body and act as natural healers. Studies suggest that when used for medical purposes, stem cells have the potential to accelerate tissue repair, stimulate tissue regeneration, and decrease inflammation.”
Bursa sacs are key to the mobility of our joints. However, when they become damaged, our range of movement can become suddenly inhibited. Bursitis can be caused by a number of factors, such as repeated pressure on a joint due to activities like physical work or gardening; or there may be an underlying problem with the structure of a bone or joint, which may be linked to causes such as sports injuries, gout, or arthritis.
Research has shown that when stem cells are introduced into a part of the body damaged by injury or arthritis, it may help to reduce pain and improve joint function. Hence for certain patients, stem cells may provide a promising alternative for the treatment of the underlying causes of chronic bursitis.
Healthy joints rely on a matrix of connective tissues to facilitate movement, offer support and provide shock absorption. This requires healthy bursa sacs, along with healthy cartilage, tendons, and ligaments.
Wear and tear can lead to osteoarthritis. Pain and inflammation can also be caused by rheumatoid arthritis, which is an autoimmune disorder that attacks the joints. Bursitis can also be linked to gout, which is caused by a build up of uric acid.
Stem cells are known to play an important role in the boy’s ability to regenerate. Studies have shown that stem cell therapy has promising potential to treat degenerative conditions such as arthritis, as well as helping to heal injuries, or reduce uric acid.
Stem cells are special types of cell that occur naturally within the body. They have the ability to replicate themselves or develop into different types of cells through a process known as differentiation.
Hence stem cells have the potential to become new cells in order to perform specific functions. For example, they can differentiate to become blood cells or other types of cell that are active within the immune system. This process enables stem cells not only to play a unique role in the body’s ability to heal itself, but also to encourage the growth of healthy tissue.
Whilst stem cell therapy is relatively new, stem cells have been the subject of over 40 years of research and there have been a large number of clinical trails. A limited number of treatments for certain medical conditions are now available in the UK.
When used for medical purposes, research suggests stem cells can accelerate tissue repair, stimulate tissue regeneration, decrease inflammation, and stimulate new blood vessel growth.
There are number of effective treatments for bursitis, which your doctor can advise upon. In many cases it may be a temporary condition, the symptoms of which can be treated with painkillers and by applying a cold temperature to affected areas.
More severe cases may require antibiotics, steroids injections, or surgery. However, those patients seeking alternatives may choose stem cell therapies for underlying conditions that cause bursitis.
Research has shown promising results. For example, in 2020 a meta-analysis of stem cell therapy for osteoarthritis of the knee concluded that it “considerably reduces pain with no obvious additional side effects”.
Stem cell therapy may be considered for people who require an alternative approach to established procedures. It may be suitable for patients aged 18 to 75, or children in special circumstances, whose condition is stable enough to undergo treatment.
The first stage is to book a consultation with a qualified medical practitioner, who will assess your medical history in order to potentially make a pre-approval application. A multi-disciplinary panel of experts will then consider your application.
If you application is approved, you will then be invited undergo a full health screening and detailed tests to ensure stem cell treatment is an appropriate approach for you. Provided you pass the assessment criteria, you may then begin treatment.
Patients generally require a preparation period that may involve a number of procedures to ensure your regenerative system is at its most receptive. The stem cells can typically then be injected into the body, which depending on the nature of your condition can either be done by intra-tissue injection.
The stem cells may be either ‘autologous’ or ‘allogeneic’. Autologous stem cells are processed after being harvested from tissue from the patient’s own body, whereas allogeneic stem cells are cultured in a laboratory from a donated source. In our clinics we only use ‘Autologous’ tissue- derived cells. ‘Allogeneic’ cells are currently used for research purposes, or by the NHS for bone marrow transplantation.
Stem cell therapies are classed as nouvelle treatments or ‘specials’, which are a permissible category of medicines that are available to meet the clinical needs of an individual patient.
The progress of stem cell patients is carefully monitored and the treating team have a regulatory duty to report any relevant findings to the responsible research NHS Body, with a view to stem cell therapy becoming a standardised licensed treatment in the future.
Can’t find the answer you’re looking for?
Click here to ask us your question.
The Cellular & Regenerative practice in Harley Street was co-founded by Dr Aamer Khan, author of the forthcoming book, ‘Aesthetic Treatments in Regenerative Medicine: Stem Cells, Stromal Vascular Fraction, Platelet Rich Plasma, and Platelet Rich Fibrin.’
Qualifying as a Doctor at the University of Birmingham in 1986 with an MB ChB (Bachelor of Medicine, Bachelor of Surgery), Dr Khan completed his postgraduate training in University Hospitals Birmingham. He spent 24 years working within the NHS, including many years in General Practice in a community with the largest proportion of elderly population in the UK. This led to his passion to study cellular and regenerative medicine, and develop an integrative approach to his medical practice.
As part of his cellular and regenerative interest, Dr. Khan’s Clinic, was one of the first to work with Cytori Stem Cell Technologies in 2008. In 2010, he retired from the NHS to refine protocols at the Harley Street Skin Clinic, and develop his integrative medical practice and the Cellular + Regenerative clinic.
Dr Mike Tee MB, BChir, BSc (Hons), DLO, DRCOG, MRCGP, is a Cambridge medical graduate, and has over 25 years of experience in the medical profession. Dr Tee is well regarded as an expert in Dermal Fillers, PRP, Thread Lifts, Mole Removal & dermatological minor surgery. Dr. Tee has worked very closely with Dr. Khan and developed a wealth of knowledge and expertise in integrative and regenerative medicine.
WebMD: What is Bursitis?
[https://www.webmd.com/pain-management/arthritis-bursitis]
Arthritis Foundation: Bursitis
[https://www.arthritis.org/diseases/bursitis]
NHS: Bursitis
[https://www.nhs.uk/conditions/bursitis/]
Mesenchymal stem cells in knee osteoarthritis treatment:
A systematic review and meta-analysis
[https://pubmed.ncbi.nlm.nih.gov/32913710/]
Mesenchymal Stem Cells Improve Rheumatoid ritis Progression
by Controlling Memory T Cell Response
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477064/ ]
Mesenchymal stem cells – a promising strategy for
treating knee osteoarthritis
[https://online.boneandjoint.org.uk/doi/full/10.1302/2046-3758.910.BJR-2020-0031.R3 ]
Clinical efficacy and safety of stem cell therapy for knee osteoarthritis
[https://pubmed.ncbi.nlm.nih.gov/32176071/ ]